The Securities and Exchange Commission (SEC) has launched an investigation into Clover Health Investments in response to scathing allegations made against the Medicare provider by short-seller Hindenburg Research.
Clover Health disclosed in a regulatory filing Friday that it received a letter from the SEC “following the publication of an article by Hindenburg Research” a day prior. The company said the SEC has requested “document and data preservation” for the period Jan. 1, 2020, to the present, “relating to certain matters that are referenced in the article.”
